The CR that was adopted on Thursday will provide funding for two weeks, which lawmakers hope will give them enough time to iron out the details for a larger spending package. TSCL will be following the negotiations closely in the coming days and we will post updates here in the Legislative News section of our website. .The following four bills were the focus of Legislative Liaison Kluck's meetings on Capitol Hill in December… .Healthcare researchers are questioning the surge in medical testing, particularly the aggressive use of advanced radiology tests like CTs, MRIs and ultrasounds. Their use has become routine, but doctors are not necessarily diagnosing more diseases and the tests can expose patients to high levels of radiation that can cause cancer. Some critics blame "defensive medicine" to avoid malpractice suits, but that's only part of the problem. Some critics say that the tests are becoming a crutch as doctors have less and less time to spend with patients. And all say that the profit motives give doctors incentives to over prescribe the tests. .For more information about these and other TSCL-backed bills, visit the Bill Tracking section of our website. To follow The Senior Citizens League's work on Capitol Hill, follow us on Twitter. .TSCL will be keeping a close eye on the budget discussions in the weeks ahead since a government shutdown could impact the Social Security and Medicare programs negatively. We will post updates here in the Legislative News section of our website, or over on our Facebook page. .Trump's administration "has decided to pursue a radical and dangerous policy to set prices based on rates paid in countries that he has labeled as socialist, which will harm patients today and into the future," Stephen Ubl, the head of PhRMA, said in a statement. .The exact mechanisms for enacting the provisions therein — such as requiring manufacturers to reveal their development costs — remain unclear. The industry has previously protected development data as a trade secret. The bills would also require "reasonable pricing clauses" be included in agreements between drug companies and agencies funding their work. They propose waiving exclusive licenses for COVID-19 drugs, allowing competitors to sell the same products as long as they pay the patent holder royalties. .The other rule concerns drug rebates involving Medicare Part D. The Department of Health and Human Services (HHS) said that last year Part D rebates totaled .8 billion, representing an average discount of nearly 30% for brand drugs. .Last week House Appropriations Military Construction-VA Chair Debbie Wasserman Schultz (D-Fla.) pushed a Department of Veterans Affairs official at a hearing to work on a plan to offer coronavirus vaccines to veterans even if they are not eligible for VA health care.